Meetings: Medicare Coverage Advisory Committee,

Text

---

Federal Register: November 15, 1999 (Volume 64, Number 219)NoticesPage 61892-61893From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr15no99-89

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Care Financing Administration

HCFA-3027-NMedicare Program; Meeting of the Executive Committee of the Medicare Coverage Advisory Committee--December 8, 1999

AGENCY: Health Care Financing Administration (HCFA), HHS.

ACTION: Notice of meeting.

SUMMARY: This notice announces a public meeting of the Executive Committee of the Medicare Coverage Advisory Committee (MCAC). The Committee provides advice and recommendations to the agency about clinical coverage issues. The Committee will hear reports from recent meetings of MCAC medical specialty panels. The Committee will also consider how to provide guidance to, and substantive coordination among, MCAC panels. For example, the Committee will consider the levels of evidence, types of information needed, and the nature of issues that will be considered by the medical specialty panels at future public meetings. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10 (a)(1) and (a)(2)).

DATES:

The Meeting: December 8, 1999, from 8 a.m. until 4 p.m., E.D.T.

Deadline for Presentations and Comments: Submit formal presentations and written comments to the For Further Information Contact by November 18, 1999, 5 p.m., E.S.T.

Special Accomodations: Persons attending the meeting who are hearing or visually impaired and have special requirements, or a condition that requires special assistance or accommodations, must notify the Executive Secretary by November 18, 1999, 5 p.m., E.D.T.

ADDRESSES:

The Meeting: The meeting will be held at the Health Care Financing Administration, Main Auditorium, 7500 Security Boulevard, Baltimore, Maryland 21244.

Presentations and Comments: Submit formal presentations and written comments to Sharon K. Lappalainen, Executive Secretary; Office of Clinical Standards and Quality; Health Care Financing Administration; 7500 Security Boulevard; Mail Stop S3-02-01; Baltimore, MD 21244.

Website: You may access up-to-date information on this meeting at www.hcfa.gov/quality/8b.htm.

SUPPLEMENTARY INFORMATION:

On August 13, 1999, we published a notice (64 FR 44231) to establish the Medicare Coverage Advisory Committee (MCAC) to provide advice and recommendations to us about clinical coverage issues. This notice announces the following public meeting of the MCAC:

Current Members of the Committee

Thomas V. Holohan, M.A., M.D., (FACP); Leslie P. Francis, JD, Ph.D.; John H. Ferguson, M.D.; Robert L. Murray, Ph.D.; Alan M. Garber, M.D., Ph.D.; Michael D. Maves, M.D., M.B.A.; David M. Eddy, M.D., Ph.D.; Frank J. Papatheofanis, M.D., Ph.D.; Harold C. Sox, M.D.; Ronald M. Davis, M.D.; Daisy Alford-Smith, Ph.D.; Joe W. Johnson, D.C.; Robert H. Brook, M.D., Sc.D.; Linda A. Bergthold, Ph.D.; and Randel E. Richner, M.P.H.

Meeting Topic

The Committee will hear reports from recent meetings of MCAC medical specialty panels. The Committee will also consider how to provide guidance to, and substantive coordination among, MCAC panels. For example, the Committee will consider the levels of evidence, types of information needed, and the nature of issues that will be considered by the medical specialty panels at future public meetings.

Procedure and Agenda

This meeting is open to the public. The Committee will hear oral presentations from the public for approximately 90 minutes on the day of the meeting. The Committee may limit the number and duration of oral presentations to the time available. If you wish to make formal presentations, you must notify the For Further Information Contact, and submit the following by the Deadline for Presentations and Comments date listed in the Dates section of this notice: a brief statement of the general nature of the information you wish to present, the

[Page 61893]names and addresses of proposed participants, and an estimate of the time required to make the presentation. We will request that you declare at the meeting whether or not you have any financial involvement with manufacturers of any items or services being discussed (or with their competitors).

After public presentation, we will make a presentation to the Committee. After our presentation, the Committee will deliberate openly on the topic. Interested persons may observe the deliberations, but the Committee will not hear further comments during this time except at the request of the chairperson. At the end of the Committee deliberations, the Committee will allow a 30-minute open public session for any attendee to address issues specific to the topic. After which, the members will vote and the Committee will make its recommendation.

Authority: 5 U.S.C. App. 2, section 10 (a)(1) and (a)(2).

(Catalog of Federal Domestic Assistance Program No. 93.774, Medicare--Supplementary Medical Insurance Program)

Dated: November 5, 1999. Jeffrey L. Kang, Director, Office of Clinical Standards and Quality, Health Care Financing Administration.

FR Doc. 99-29670Filed11-12-99; 8:45 amBILLING CODE 4120-01-P

If you are already a vLex customer, access here

---